Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN) [NA]
A completed evaluation of a natural experiment aimed at improving statewide depression care in Minnesota.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE) [NA]
Completed clinical trial evaluating a psychological intervention in recipients of lung transplants. The study addressed conditions of lung d…
-
FDA approval · 2014-07-11FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2014-07-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride (Teva Pharmaceuticals USA, Inc.) under ANDA071525. This action grants ap…
-
FDA approval · 2014-07-11FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, authorizing a new generic fluoxetine product under…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Studying the Impact of Medication Counselling by Community Pharmacists in Patients Starting a Treatment With Antidepressants
This completed trial studied the impact of medication counselling by community pharmacists on patients starting antidepressants.
-
CLINICAL_TRIALS research · 2014-07-11Clinical Trial Update: Adapted and Translated, Adolescent Depression, Internet Intervention [NA]
A clinical trial is evaluating an adapted and translated internet-based intervention for depression in adolescents.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Relapse Prevention for Suicidal Dually Diagnosed Youths [Phase 1]
Phase 1 trial evaluating relapse prevention in suicidal youths with dual diagnoses has completed. No results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Effectiveness of a Depression Care Management Initiative in Home Healthcare [NA]
Clinical trial update on the effectiveness of a depression care management initiative in home healthcare; the trial's current status is unkn…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Working Memory Training for Dysphoric Students [NA]
A clinical trial conducted at Erasmus Medical Center evaluating working memory training for students with depressive symptoms has completed.
-
FDA approval · 2014-07-08FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
The FDA has approved a supplemental application for Celexa (citalopram) from Allergan, Inc.
-
FDA approval · 2014-07-08FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Bupropion & Cardio Birth Defect (Slone)
This is a completed clinical trial update about the use of bupropion in major depressive disorder. The snippet does not provide specific res…
-
CLINICAL_TRIALS research · 2014-07-04Clinical Trial Update: Barriers to Mental Healthcare Utilization in Parkinson's Disease
A completed clinical trial conducted by Rutgers investigating barriers to utilizing mental healthcare in individuals with Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs [Phase 2]
Phase 2 trial evaluating ziprasidone augmentation of SSRI therapy in adults with major depressive disorder who did not adequately respond to…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Physiologic Monitoring of Antidepressant Treatment Response [Phase 4]
A Phase 4 clinical trial from UCLA studied physiologic monitoring to predict antidepressant treatment response in depression. The study stat…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder [Phase 2]
A 12-week, placebo-controlled Phase 2 trial evaluating ziprasidone as monotherapy for major depressive disorder has completed, with results …
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study) [Phase 4]
Phase 4 study in adolescents with major depressive disorder evaluating biomarkers of antidepressant treatment; the study is reported as comp…
-
FDA approval · 2014-07-02FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for NORPRAMIN (desipramine hydrochloride) filed by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS safety_alert · 2014-07-02Clinical Trial Update: Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
Clinical trial update noting a potential association between exposure to pravastatin and paroxetine and the development of Type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001) [Phase 2]
Phase 2 trial to determine the maximum tolerated dose of Org 26576 in participants with major depressive disorder has completed with results…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Veteran Health Study
The Veterans Health Study sponsored by the US Department of Veterans Affairs has completed, focusing on post-traumatic stress disorder and d…
-
CLINICAL_TRIALS withdrawal · 2014-07-02Clinical Trial Update: Groups for Regaining Our Wellbeing (GROW) [Phase 2, Phase 3]
The GROW trial for post-traumatic stress disorder and depression (Phase 2/Phase 3) sponsored by the US Department of Veterans Affairs has be…
-
FDA approval · 2014-07-01FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance…
-
FDA approval · 2014-07-01FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., confirming approval of a generic tr…